Sale!

ACO2 Gene Cerebellar-Retinal Degeneration Infantile Genetic Test

4,400 د.إ

-21%

The ACO2 gene cerebellar-retinal degeneration infantile genetic test is a specialized diagnostic procedure designed to identify mutations in the ACO2 gene, which are linked to a rare, inherited neurodegenerative disorder. This condition is characterized by early-onset degeneration of the cerebellum and retina, leading to symptoms such as poor muscle coordination, visual impairment, and intellectual disability. Early detection through this genetic test can facilitate timely intervention and management strategies to improve the quality of life for affected individuals.

The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the ACO2 gene test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify mutations in this specific gene. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, paving the way for personalized treatment plans and preventive measures for associated conditions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ACO2 Gene Cerebellar-retinal degeneration infantile Genetic Test

At DNA Labs UAE, we offer the ACO2 Gene Cerebellar-retinal degeneration infantile Genetic Test. This test helps in diagnosing a rare genetic disorder that affects the development and function of the cerebellum and retina.

Test Details

The ACO2 gene is associated with cerebellar-retinal degeneration, infantile. This disorder is characterized by progressive ataxia (lack of muscle coordination), vision loss, and intellectual disability.

Our NGS (next-generation sequencing) genetic testing method allows us to analyze DNA and detect mutations in the ACO2 gene that may be responsible for cerebellar-retinal degeneration, infantile. This type of testing is crucial for diagnosing the disorder and providing information for genetic counseling and management of the condition.

Components

  • Test Name: ACO2 Gene Cerebellar-retinal degeneration infantile Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Ophthalmology Disorders
  • Doctor: Ophthalmologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the ACO2 Gene Cerebellar-retinal degeneration infantile Genetic Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the ACO2 Gene Cerebellar-retinal degeneration infantile Genetic Test gene ACO2.

Cost

The ACO2 Gene Cerebellar-retinal degeneration infantile Genetic Test is priced at 4400.0 AED.

Test Name ACO2 Gene Cerebellar-retinal degeneration infantile Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ACO2 Gene Cerebellar-retinal degeneration, infantile NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACO2 Gene Cerebellar-retinal degeneration, infantile NGS Genetic DNA Test gene ACO2
Test Details

The ACO2 gene is associated with cerebellar-retinal degeneration, infantile, a rare genetic disorder that affects the development and function of the cerebellum and retina. This disorder is characterized by progressive ataxia (lack of muscle coordination), vision loss, and intellectual disability.

NGS (next-generation sequencing) genetic testing is a method of analyzing DNA that can detect mutations in the ACO2 gene that may be responsible for cerebellar-retinal degeneration, infantile. This type of testing can help diagnose the disorder and provide information for genetic counseling and management of the condition.